MYO5C expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.174200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.892600E-01
Normal-vs-Stage2
1.718010E-01
Normal-vs-Stage3
8.859000E-01
Normal-vs-Stage4
1.787160E-01
Stage1-vs-Stage2
9.737000E-01
Stage1-vs-Stage3
1.869400E-01
Stage1-vs-Stage4
9.257200E-01
Stage2-vs-Stage3
8.126000E-02
Stage2-vs-Stage4
8.849600E-01
Stage3-vs-Stage4
1.077430E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.234000E-01
Normal-vs-AfricanAmerican
3.125200E-01
Normal-vs-Asian
2.570600E-01
Caucasian-vs-AfricanAmerican
9.292400E-01
Caucasian-vs-Asian
4.996200E-01
AfricanAmerican-vs-Asian
6.746200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.023600E-01
Normal-vs-Female
2.545200E-01
Male-vs-Female
3.163200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.280800E-01
Normal-vs-Age(41-60Yrs)
1.775620E-01
Normal-vs-Age(61-80Yrs)
2.372600E-01
Normal-vs-Age(81-100Yrs)
4.550600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.684000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.268200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.844400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.549400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.922600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.062600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.388390E-01
Normal-vs-Daily Drinker
4.286400E-01
Normal-vs-Weekly Drinker
5.440200E-01
Normal-vs-Occasional Drinker
1.405020E-01
Normal-vs-Social Drinker
3.006800E-01
Non Drinker-vs-Daily Drinker
2.478600E-01
Non Drinker-vs-Weekly Drinker
2.817200E-01
Non Drinker-vs-Occasional Drinker
6.607800E-01
Non Drinker-vs-Social Drinker
3.801800E-01
Daily Drinker-vs-Weekly Drinker
9.131400E-01
Daily Drinker-vs-Occasional Drinker
4.832200E-01
Daily Drinker-vs-Social Drinker
8.355800E-01
Weekly Drinker-vs-Occasional Drinker
4.822600E-01
Weekly Drinker-vs-Social Drinker
7.806000E-01
Occasional Drinker-vs-Social Drinker
6.223600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.422200E-02
Normal-vs-Grade 2
9.175800E-03
Normal-vs-Grade 3
3.881400E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.940850E-01
Grade 1-vs-Grade 3
6.740200E-02
Grade 1-vs-Grade 4
3.422200E-02
Grade 2-vs-Grade 3
4.094800E-01
Grade 2-vs-Grade 4
9.175800E-03
Grade 3-vs-Grade 4
3.881400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.178800E-01
Normal-vs-NonDiabetic
2.019400E-01
Diabetic-vs-NonDiabetic
5.552100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.998830E-01
Normal-vs-NoPancreatitis
2.528800E-01
Pancreatitis-vs-NoPancreatitis
3.602000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.218600E-01
Normal-vs-N1
1.708190E-01
N0-vs-N1
1.985840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.360400E-02
Normal-vs-TP53-NonMutant
2.214600E-01
TP53-Mutant-vs-TP53-NonMutant
6.821900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
